Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

University Health Network

610 University Avenue, M5G 2M9

About the sponsor

Research activity includes resectable hepatocellular carcinoma, with interest in perioperative therapy and immunotherapy approaches centered on durvalumab and tremelimumab.

  • Hepatocellular carcinoma
  • Resectable liver cancer
  • Checkpoint inhibitor combinations

The clinical focus is on treatment strategies for surgically manageable liver malignancy within a multi-site research network.

About Specializations

University Health Network runs clinical trials in conditions such as Cervix carcinoma, Hepatocellular carcinoma, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Cervix carcinoma

Recruiting
Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Carboplatin
  • Sponsor:Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting

Hepatocellular carcinoma

Not recruiting
Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:University Health Network

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.